Novartis AG Sponsored ADR (NVS)
NYSE
Closed
Aug 21, 2026
Day's Range
156.1052 wk Range
121.57Overview - NVS - Novartis AG Sponsored ADR
Key Statistics
Valuation
Enterprise Value
343.74B
P/E (Trailing)
‪23.99‬
P/E (Forward)
‪16.19‬
PEG Ratio
‪-1.37‬
Price / Sales (TTM)
‪5.32‬
Price / Book
‪7.26‬
EV / EBITDA
‪14.88‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
1.90B
Float
1.85B
Short % of Shares Outstanding
‪0.28%‬
Held by Insiders
‪0.01%‬
Held by Institutions
‪7.26%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪154.33‬
200-Day Avg
‪148.25‬
Dividends
Payout Ratio
‪71.59%‬
Frequency
Annual
Analyst Consensus
12 analysts
Average price target
‪$ 157.15‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NVS - Novartis AG Sponsored ADR
Peers - NVS - Novartis AG Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- NVSNYSENovartis AG Sponsored ADR301.94BMarket Cap+21.29%52-week change24.00P/E (Trailing)‪22.50%‬Profit Margin
- LLYNYSEEli Lilly and Company1.11TMarket Cap+44.61%52-week change42.21P/E (Trailing)‪33.52%‬Profit Margin
- JNJNYSEJohnson & Johnson651.25BMarket Cap+33.98%52-week change31.50P/E (Trailing)‪21.48%‬Profit Margin
- ABBVNYSEAbbVie Inc.468.21BMarket Cap+21.67%52-week change75.06P/E (Trailing)‪9.80%‬Profit Margin
- MRKNYSEMerck & Co., Inc.376.36BMarket Cap+44.08%52-week change122.04P/E (Trailing)‪4.76%‬Profit Margin
- SANNYSEBanco Santander S.A. Sponsored ADR212.65BMarket Cap+34.20%52-week change14.27P/E (Trailing)‪33.46%‬Profit Margin
- NVONYSENovo Nordisk A/S206.68BMarket Cap-20.54%52-week change11.59P/E (Trailing)‪35.34%‬Profit Margin
Profile Summary - NVS - Novartis AG Sponsored ADR
About
Novartis AG Sponsored ADR represents ownership in Novartis AG, a global healthcare company focused on researching, developing, manufacturing, and marketing innovative medicines. Through this ADR structure, U.S. investors can gain exposure to Novartis AG shares in U.S. dollars, with each depositary receipt backed by an…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
